Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations: 2019-2025

Historic Income from Continuing Operations for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$9.1 million.

  • Biodesix's Income from Continuing Operations rose 14.17% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 8.24%. This contributed to the annual value of -$42.8 million for FY2024, which is 15.96% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Income from Continuing Operations is -$9.1 million, which was up 21.45% from -$11.6 million recorded in Q2 2025.
  • Biodesix's 5-year Income from Continuing Operations high stood at -$6.2 million for Q1 2021, and its period low was -$18.8 million during Q1 2023.
  • In the last 3 years, Biodesix's Income from Continuing Operations had a median value of -$10.6 million in 2024 and averaged -$11.4 million.
  • Per our database at Business Quant, Biodesix's Income from Continuing Operations tumbled by 292.35% in 2021 and then soared by 44.05% in 2023.
  • Over the past 5 years, Biodesix's Income from Continuing Operations (Quarterly) stood at -$13.2 million in 2021, then fell by 24.78% to -$16.4 million in 2022, then spiked by 44.05% to -$9.2 million in 2023, then grew by 8.67% to -$8.4 million in 2024, then rose by 14.17% to -$9.1 million in 2025.
  • Its last three reported values are -$9.1 million in Q3 2025, -$11.6 million for Q2 2025, and -$10.8 million during Q1 2025.